Progesterone Receptor and Progesterone Receptor B Isoform Expression and Their Clinical Significance in Endometrial Adenocarcinoma

张俊梅,周蓉,杨大同,魏丽惠,屠铮,虞有智,张宏伟
DOI: https://doi.org/10.3969/j.issn.1672-1861.2002.02.010
2002-01-01
Abstract:Objective To study the progesterone receptor (PR) and progesterone receptor B ( PR B) expression and their clinical significance in endometrial adenocarcinoma. Methods The specimens of 30 patients with endometrial adenocarcino-ma were used in this study. All the specimens were formalin - fixed, paraffin - embedded, cut and mounted onto the slides. Sections were stained for PR and PR B by the immunohistochemistry technique.Ten specimens of normal proliferative phase endometri-um were also detected as control group. Results PR and PR B were nuclei receptors. Positive expression of PR and PR B were in 93.33% and 50% of the cancer specimens respectively. All specimens of control group were positive staining of the PR and PR B. The expression of PR had no relations with the differentiation and clinical stage of the cancer. There were more well - differentiated tumors in PR B positive specimens than that in PR B negative specimens, but the expression of PR B had no relations with the clinical stage of the cancer. Conclusions PR and PR B had different expression in endometrial adenocarcinoma. The expression rate of PR B had positive correlation with the differentiation of the cancer. To detect the expression of PR and PR B may have some roles in the guidance of the endocrinotherapy and prognosis of the endometrial adenocarcinoma.
What problem does this paper attempt to address?